Adalank (N-Acetyl Selank Amidate) vs BPC-157
Updated July 21, 2026 · Reviewed by the PeptidesDB Editorial team
A data-driven comparison of Adalank (N-Acetyl Selank Amidate) and BPC-157 (also searched as BPC-157 vs Adalank (N-Acetyl Selank Amidate)) — effect profiles, evidence, side effects, and which suits weight loss, muscle, or healing goals.
Verdict
Adalank (N-Acetyl Selank Amidate) centers on neuro, while BPC-157 leans toward healing. On indexed research, BPC-157 is ahead (Adalank (N-Acetyl Selank Amidate): 0 studies, Emerging; BPC-157: 6, Human evidence). Choose by goal — and read the primary studies. This is research information, not medical advice.
Key takeaways
- •Adalank (N-Acetyl Selank Amidate) is strongest for neuro; BPC-157 for healing.
- •Evidence: Adalank (N-Acetyl Selank Amidate) Emerging (0 studies) vs BPC-157 Human evidence (6).
- •Both are research-use compounds — not FDA-approved.
Effect profiles, overlaid
At a glance
N-Acetyl Selank Amidate | Enhanced Tuftsin Analog
Body Protection Compound-157 | Pentadecapeptide
Adalank (N-Acetyl Selank Amidate) vs BPC-157: side-by-side
| Metric | Adalank (N-Acetyl Selank Amidate) | BPC-157 |
|---|---|---|
| Class | Cognitive | Healing |
| Regulatory status | Research use only | Research use only |
| Evidence grade | Emerging | Human evidence |
| Studies indexed | 0 | 6 |
| Research level | Emerging | Extensively Studied |
| Strongest effect | Neuro & mood | Healing & recovery |
| Healing & recovery | 0.0 | 4.3▲ |
| Muscle & body comp | 0.0 | 3.3▲ |
| Metabolic & appetite | 0.0 | 2.3▲ |
| Neuro & mood | 4.0▲ | 3.0 |
| Sleep & circadian | 0.0 | 0.7▲ |
| Inflammation & immune | 0.0 | 4.0▲ |
| Skin & aesthetics | 0.0 | 2.0▲ |
▲ marks the higher community effect score (0–5 perceived-effect signal, not clinical efficacy).
Mechanism & pharmacokinetics
| Property | Adalank (N-Acetyl Selank Amidate) | BPC-157 |
|---|---|---|
| Mechanism | Anxiolytic heptapeptide (Tuftsin analog) | Body-protective compound (pentadecapeptide); cytoprotective, pro-angiogenic signaling |
| Route | Intranasal / subcutaneous (research use) | Subcutaneous / oral (research use) |
Established pharmacology — curated for well-characterized compounds and AI-summarized otherwise. A blank (—) means no reliable single value is published (half-life figures for some peptides genuinely disagree across sources). Verify against primary sources such as FDA labels and ClinicalTrials.gov.
What is Adalank (N-Acetyl Selank Amidate)?
Adalank (N-Acetyl Selank Amidate) is a modified analog of the Russian heptapeptide Selank, designed for enhanced metabolic stability and investigated for anxiolytic and nootropic effects.
Full Adalank (N-Acetyl Selank Amidate) profile, mechanism & studies →What is BPC-157?
Body Protective Compound often discussed for soft-tissue repair, GI support, and inflammation modulation.
Full BPC-157 profile, mechanism & studies →Which is better for your goal?
| Goal | Better fit | Why |
|---|---|---|
| Healing | BPC-157 | 4.3/5 effect signal |
| Muscle | BPC-157 | 3.3/5 effect signal |
| Metabolic | BPC-157 | 2.3/5 effect signal |
| Neuro | Adalank (N-Acetyl Selank Amidate) | 4.0/5 effect signal |
| Sleep | BPC-157 | 0.7/5 effect signal |
| Inflammation | BPC-157 | 4.0/5 effect signal |
| Skin | BPC-157 | 2.0/5 effect signal |
Fit reflects community-perceived effect profiles — not head-to-head trials. Read each peptide's studies before deciding.
Can you stack Adalank (N-Acetyl Selank Amidate) and BPC-157?
People sometimes combine peptides that target different pathways, but there is little controlled research on this specific pairing and the interactions aren't well characterized. Because neither compound is FDA-approved, we don't publish stacking or dosing protocols here. Any combination should be discussed with a qualified clinician.
Adalank (N-Acetyl Selank Amidate) vs BPC-157: side effects
No community-reported effects logged yet.
- improved healing28
- flushing14
- vivid dreams11
- nausea3
- anxiety2
Anonymous community reports (count = number of reports), not clinical incidence rates.
What the research says
Adalank (N-Acetyl Selank Amidate) has 0 approved studies indexed (Emerging), and BPC-157 has 6 (Human evidence). The Librarian re-checks PubMed, Europe PMC and ClinicalTrials daily, so these counts move. Open each profile to read the summaries and sources.
Frequently asked questions
Is Adalank (N-Acetyl Selank Amidate) or BPC-157 better?
It depends on your goal. Adalank (N-Acetyl Selank Amidate) is strongest for neuro; BPC-157 for healing. BPC-157 has more indexed studies (6). See the goal-by-goal breakdown above.
Is Adalank (N-Acetyl Selank Amidate) or BPC-157 better for weight loss?
BPC-157 shows the stronger metabolic & appetite profile (2.3/5) in community effect data — though weight-loss outcomes depend on the individual and the evidence base.
Is Adalank (N-Acetyl Selank Amidate) or BPC-157 better for muscle?
BPC-157 leads on the muscle & body-composition axis (3.3/5).
Which has more research, Adalank (N-Acetyl Selank Amidate) or BPC-157?
Adalank (N-Acetyl Selank Amidate) has 0 approved studies indexed (Emerging); BPC-157 has 6 (Human evidence). Higher counts mean more to read, not proven superiority.
Can you stack Adalank (N-Acetyl Selank Amidate) and BPC-157?
Some users combine peptides, but there's little controlled data on this specific pairing, and interactions aren't well characterized. We don't publish stacking protocols for compounds that aren't FDA-approved. Discuss any combination with a qualified clinician.
What are the side effects of Adalank (N-Acetyl Selank Amidate) vs BPC-157?
Adalank (N-Acetyl Selank Amidate): no community-reported effects logged yet. BPC-157: improved healing, flushing, vivid dreams. These are anonymous reports, not incidence rates — see each profile.
Is Adalank (N-Acetyl Selank Amidate) or BPC-157 FDA-approved?
Adalank (N-Acetyl Selank Amidate) is a research-use compound and is not FDA-approved. BPC-157 is not FDA-approved. Research-use status is not a legal clearance to compound or use in humans.
Is BPC-157 better than Adalank (N-Acetyl Selank Amidate)?
For healing, BPC-157 has the edge; for neuro, Adalank (N-Acetyl Selank Amidate) does. Neither is universally "better" — it's goal-dependent, and both should be weighed against their evidence base above.
Comparing related peptides
Regulatory & legal status
Adalank (N-Acetyl Selank Amidate) and BPC-157 are research-use compounds and are not FDA-approved for human use. FDA approval and compounding rules for peptides change frequently, and research-use status is not a legal clearance for human use. The FDA does not review compounded drugs for safety, effectiveness, or quality. Verify current status with primary sources before acting. Last reviewed July 21, 2026.